Podcast
What Investors Look For in the Aesthetic Sector
Aesthetics represents a major financial opportunity for many investors and our panelist are taking full advantage of it. This month’s podcast features a panel discussion from the top people and firms who have a track record of successful investments in aesthetics recorded live during this year’s Aesthetics Innovation Summit. There is no better group of…
Read MoreAesthetics Innovator Podcast: Clash of the Toxin Titans at AIS!
Executives from the top toxin brands weigh in on the media response to the launch of Jeuveau. This months podcast was a live recording of the Toxin Titans Part II panel from the recent Aesthetics Innovation Summit. Dr Grant Stevens led the discussion on the risk of price erosion and commoditization as competitors enter the…
Read MoreSimeon Wall, Jr., MD, Louis Bucky See Growing Influence for Physicians/Entrepreneurs in Aesthetics
In this episode of the Aesthetics Innovator’s Podcast, physicians Simeon Wall, Jr., MD and Lou Bucky, MD join Co-Host Grant Stevens, MD to discuss the role of physicians in creating new therapies for their patients. The three Aesthetics leaders also evaluate the impact of new toxins in the market as well as other new technologies…
Read MoreHintMD’s Aubrey Rankin joins host Mark Foley to discuss how HintMD discovered the true opportunity in the market and the evolution of the young organization
Aubrey Rankin, CEO and Co-Founder of HintMD shares how the young start-up’s path of discovery has created a dynamic platform that solves a key problem for doctors. Rankin gives insight into their pivot to help undertreated patients in the market. Rankin also reveals their latest data results, industry trends towards subscriptions and how their technology…
Read MoreMerz Americas’ CEO Bob Rhatigan Discusses Reclaimers, Toxin Commoditization, and Christie Brinkley
In this Aesthetics Innovators Podcast Episode, Bob Rhatigan, CEO of Merz Americas, talks with co-host Grant Stevens, MD, about the battle building in the toxin market, including Merz’s own Xeomin. Is the risk of commoditization real? Rhatigan also discusses several of the company’s effective marketing plans to target “Reclaimers” and to tout the effectiveness of…
Read MoreAllergan’s Bill Meury Sees Opportunity in M&A, Millennials, China, and Emerging Options for Toxins
William Meury, EVP, and chief commercial officer, a keynote speaker at the upcoming Aesthetics Innovation Summit, talks shop with AI Podcast co-host Grant Stevens, MD. In this conversation at Dr. Stevens’ office in Marina Del Rey, CA, the two aesthetics leaders swap insights on the meteoric growth of the aesthetics industry driven in large part…
Read MoreNew Entrant Makes Moves in the Toxin Market
In this month’s podcast David Moatazedi joins host Grant Stevens, MD to discuss the latest developments at Evolus, his new role as CEO and how doctors are involved with the company as they prepare for commercialization in 2019. David shares insight into their plans, an in-depth review of Evolus, its new management team and its…
Read MoreRevance CEO Browne Sheds Light on History, Challenges and Future Following Its Recent Clinical News
In this podcast, AIS Co-Chair Mark Foley – a successful executive in his own right – asks Dan Browne, CEO of Revance Therapeutics several compelling questions. How did his love for the outdoors lead to his career in medical technology? What led him to co-found Revance with two friends? What were some of the important…
Read MoreJoin Host Grant Stevens, MD, and Mark Foley for the First Episode of the Aesthetics Innovators Podcast
Welcome to the Aesthetics Innovators Podcast. In this episode, host Grant Stevens, MD, the founder and medical director of Marina Plastic Surgery and The Orange Twist Institute, discusses the future of aesthetics innovation with Mark Foley, the former CEO of Zeltiq. Dr. Stevens, Foley, and Josh Makower, MD, general partner at NEA, serve as co-chairs…
Read More